Evidence map›Paper›PMID 38617315›Full record

ArticlebioRxiv : the preprint server for biology2025

A versatile information retrieval framework for evaluating profile strength and similarity.

Alexandr A Kalinin, John Arevalo, Erik Serrano, Loan Vulliard, Hillary Tsang, Michael Bornholdt, Alán F Muñoz, Suganya Sivagurunathan, Bartek Rajwa, Anne E Carpenter and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Alexandr A KalininImaging Platform, Broad Institute of MIT and Harvard, Cambridge MA, USA.ORCID 0000-0003-4563-3226
John ArevaloImaging Platform, Broad Institute of MIT and Harvard, Cambridge MA, USA.ORCID 0000-0002-1138-5036
Erik SerranoDepartment of Biomedical Informatics, University of Colorado School of Medicine, Aurora CO, USA.ORCID 0000-0003-4188-9080
Loan VulliardSystems Immunology and Single-Cell Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-2260-4935
Hillary TsangImaging Platform, Broad Institute of MIT and Harvard, Cambridge MA, USA.
Michael BornholdtImaging Platform, Broad Institute of MIT and Harvard, Cambridge MA, USA.
Alán F MuñozImaging Platform, Broad Institute of MIT and Harvard, Cambridge MA, USA.ORCID 0000-0001-8698-5477
Suganya SivagurunathanImaging Platform, Broad Institute of MIT and Harvard, Cambridge MA, USA.ORCID 0000-0002-9778-5400
Bartek RajwaBindley Bioscience Center, Purdue University, West Lafayette IN, USA.ORCID 0000-0001-7540-8236
Anne E CarpenterImaging Platform, Broad Institute of MIT and Harvard, Cambridge MA, USA.ORCID 0000-0003-1555-8261
Gregory P WayDepartment of Biomedical Informatics, University of Colorado School of Medicine, Aurora CO, USA.ORCID 0000-0002-0503-9348
Shantanu SinghImaging Platform, Broad Institute of MIT and Harvard, Cambridge MA, USA.ORCID 0000-0003-3150-3025

Funding

Computational Bioscience Program Training GrantT15LM009451 · NLM · UNIVERSITY OF COLORADO DENVER · PI Katherina Kechris-Mays, Arjun Krishnan · 2007 to 2026
$11.7M
Extracting rich information from biological imagesR35GM122547 · NIGMS · BROAD INSTITUTE, INC. · PI Anne E. Carpenter · 2017 to 2026
$6.2M
NIGMS NIH HHS R35 GM122547NLM NIH HHS T15 LM009451
6 · The paper itself

Abstract

In profiling assays, thousands of biological properties are measured across many samples, yielding biological discoveries by capturing the state of a cell population, often at the single-cell level. However, for profiling datasets, it has been challenging to evaluate the phenotypic activity of a sample and the phenotypic consistency among samples, due to profiles' high dimensionality, heterogeneous nature, and non-linear properties. Existing methods leave researchers uncertain where to draw boundaries between meaningful biological response and technical noise. Here, we developed a statistical framework that uses the well-established mean average precision (mAP) as a single, data-driven metric to bridge this gap. We validated the mAP framework against established metrics through simulations and real-world data applications, revealing its ability to capture subtle and meaningful biological differences in cell state. Specifically, we used mAP to assess both phenotypic activity for a given perturbation (or a sample) as well as consistency within groups of perturbations (or samples) across diverse high-dimensional datasets. We evaluated the framework on different profile types (image, protein, and mRNA profiles), perturbation types (CRISPR gene editing, gene overexpression, and small molecules), and profile resolutions (single-cell and bulk). Our open-source software allows this framework to be applied to identify interesting biological phenomena and promising therapeutics from large-scale profiling data.

Identifiers

PMID38617315
PMCPMC11014546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.